IDH1 AND IDH2 GENE MUTATIONS ARE FREQUENT MOLECULAR LESIONS IN ACUTE MYELOID LEUKEMIA (AML) AND CONFER ADVERSE PROGNOSIS IN CYTOGENETICALLY NORMAL AML WITH NPM1 MUTATION WITHOUT FLT3-ITD

被引：0
|
作者：
Paschka, P. [1 ]
Schlenk, R. [1 ]
Gaidzik, V. [1 ]
Habdank, M. [1 ]
Kroenke, J. [1 ]
Bullinger, L. [1 ]
Spaeth, D. [1 ]
Kayser, S. [1 ]
Zucknick, M. [2 ]
Goetze, K. [3 ]
Horst, H. [4 ]
Germing, U. [5 ]
Doehner, H. [1 ]
Doehner, K. [1 ]
机构：
[1] Univ Hosp, Ulm, Germany
[2] German Canc Res Ctr, Div Biostat, D-6900 Heidelberg, Germany
[3] Tech Univ Munich, Univ Hosp, Munich, Germany
[4] Univ Hosp, Kiel, Germany
[5] Univ Hosp, Dusseldorf, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1108
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [1] Isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) mutations confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 Mutation without FLT3-ITD
    Paschka, P.
    Schlenk, R. F.
    Gaidzik, V., I
    Habdank, M.
    Kroenke, J.
    Bullinger, L.
    Spaeth, D.
    Kayser, S.
    Zucknick, M.
    Goetze, K.
    Horst, H-A
    Germing, U.
    Doehner, H.
    Doehner, K.
    ONKOLOGIE, 2010, 33 : 5 - 5
  • [2] IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
    Paschka, Peter
    Schlenk, Richard F.
    Gaidzik, Verena I.
    Habdank, Marianne
    Kroenke, Jan
    Bullinger, Lars
    Spaeth, Daniela
    Kayser, Sabine
    Zucknick, Manuela
    Goetze, Katharina
    Horst, Heinz-A.
    Germing, Ulrich
    Doehner, Hartmut
    Doehner, Konstanze
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3636 - 3643
  • [3] IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation
    Yamaguchi, Shunichiro
    Iwanaga, Eisaku
    Tokunaga, Kenji
    Nanri, Tomoko
    Shimomura, Taizo
    Suzushima, Hitoshi
    Okuno, Yutaka
    Mitsuya, Hiroaki
    Asou, Norio
    BLOOD, 2013, 122 (21)
  • [4] IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation
    Yamaguchi, Shunichiro
    Iwanaga, Eisaku
    Tokunaga, Kenji
    Nanri, Tomoko
    Shimomura, Taizo
    Suzushima, Hitoshi
    Mitsuya, Hiroaki
    Asou, Norio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (06) : 471 - 477
  • [5] HIF1a Expression Is Associated with NPM1 Mutation, but Not IDH1 or IDH2 Mutations in Acute Myeloid Leukemia with Normal Karyotype
    Hu, S.
    Ruvolo, V.
    Lu, H.
    Kantarjian, H. M.
    Wheeler, D.
    Muzny, D. M.
    Medeiros, L. J.
    Bueso-Ramos, C.
    Konopleva, M.
    Andreeff, M.
    Konoplev, S.
    LABORATORY INVESTIGATION, 2012, 92 : 342A - 342A
  • [6] HIF1a Expression Is Associated with NPM1 Mutation, but Not IDH1 or IDH2 Mutations in Acute Myeloid Leukemia with Normal Karyotype
    Hu, S.
    Ruvolo, V.
    Lu, H.
    Kantarjian, H. M.
    Wheeler, D.
    Muzny, D. M.
    Medeiros, L. J.
    Bueso-Ramos, C.
    Konopleva, M.
    Andreeff, M.
    Konoplev, S.
    MODERN PATHOLOGY, 2012, 25 : 342A - 342A
  • [7] Rapid IDH1/IDH2 Mutation Assessment in Acute Myeloid Leukemia (AML) and Glioma
    Huynh, T.
    Zhang, L.
    Li, Y.
    Solis, J.
    Stanley, A.
    Jin, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S163 - S164
  • [8] Implication of IDH1 and IDH2 gene mutations in acute myeloid leukemia
    Llopis, Laura
    Nibourel, Olivier
    Boissel, Nicolas
    Huchette, Pascal
    Renneville, Aline
    Abdelhamid, Emma
    Dombret, Herve
    Preudhomme, Claude
    HEMATOLOGIE, 2011, 17 (02): : 132 - 144
  • [9] Impact of FLT3-ITD allele ratio and ITD length on therapeutic outcome in cytogenetically normal AML patients without NPM1 mutation
    Fang Chen
    Junya Sun
    Changxin Yin
    Jiaying Cheng
    Jinle Ni
    Ling Jiang
    Qiang Wang
    Guopan Yu
    Yongqiang Wei
    Xiaoli Liu
    Jing Sun
    Bing Z. Carter
    Xuejie Jiang
    Bone Marrow Transplantation, 2020, 55 : 740 - 748
  • [10] Impact of FLT3-ITD allele ratio and ITD length on therapeutic outcome in cytogenetically normal AML patients without NPM1 mutation
    Chen, Fang
    Sun, Junya
    Yin, Changxin
    Cheng, Jiaying
    Ni, Jinle
    Jiang, Ling
    Wang, Qiang
    Yu, Guopan
    Wei, Yongqiang
    Liu, Xiaoli
    Sun, Jing
    Carter, Bing Z.
    Jiang, Xuejie
    BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 740 - 748
12345